YFA

(2R)-2-{5-fluoro-6-[4-(1-methylpiperidin-4-yl)phenyl]-4-oxoquinazolin-3(4H)-yl}-2-phenyl-N-(1,3-thiazol-2-yl)acetamide

Created:	2021-02-24
Last modified:	2022-02-23

Find Related PDB Entry
1 entries where YFA is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	68
Chiral Atom Count	1
Bond Count	73
Aromatic Bond Count	23

2D diagram of YFA

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2R)-2-{5-fluoro-6-[4-(1-methylpiperidin-4-yl)phenyl]-4-oxoquinazolin-3(4H)-yl}-2-phenyl-N-(1,3-thiazol-2-yl)acetamide
Systematic Name (OpenEye OEToolkits)	(2~{R})-2-[5-fluoranyl-6-[4-(1-methylpiperidin-4-yl)phenyl]-4-oxidanylidene-quinazolin-3-yl]-2-phenyl-~{N}-(1,3-thiazol-2-yl)ethanamide
Formula	C₃₁ H₂₈ F N₅ O₂ S
Molecular Weight	553.65
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C(C(N4C(c3c(c(c2ccc(C1CCN(C)CC1)cc2)ccc3N=C4)F)=O)c5ccccc5)(Nc6nccs6)=O
SMILES	CACTVS	3.385	CN1CCC(CC1)c2ccc(cc2)c3ccc4N=CN([CH](C(=O)Nc5sccn5)c6ccccc6)C(=O)c4c3F
SMILES	OpenEye OEToolkits	2.0.7	CN1CCC(CC1)c2ccc(cc2)c3ccc4c(c3F)C(=O)N(C=N4)C(c5ccccc5)C(=O)Nc6nccs6
Canonical SMILES	CACTVS	3.385	CN1CCC(CC1)c2ccc(cc2)c3ccc4N=CN([C@@H](C(=O)Nc5sccn5)c6ccccc6)C(=O)c4c3F
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN1CCC(CC1)c2ccc(cc2)c3ccc4c(c3F)C(=O)N(C=N4)[C@H](c5ccccc5)C(=O)Nc6nccs6
InChI	InChI	1.03	InChI=1S/C31H28FN5O2S/c1-36-16-13-21(14-17-36)20-7-9-22(10-8-20)24-11-12-25-26(27(24)32)30(39)37(19-34-25)28(23-5-3-2-4-6-23)29(38)35-31-33-15-18-40-31/h2-12,15,18-19,21,28H,13-14,16-17H2,1H3,(H,33,35,38)/t28-/m1/s1
InChIKey	InChI	1.03	KNGPHZUBZOTRTG-MUUNZHRXSA-N

Related Resource References

Resource Name	Reference
PubChem	162625309

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.